Παραπομπή APA

Seufert, J. (2015). SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: Focus on canagliflozin. Diabetes Metab Syndr Obes.

Παραπομπή Chicago Style

Seufert, Jochen. "SGLT2 Inhibitors – an Insulin-independent Therapeutic Approach for Treatment of Type 2 Diabetes: Focus On Canagliflozin." Diabetes Metab Syndr Obes 2015.

Παραπομπή MLA

Seufert, Jochen. "SGLT2 Inhibitors – an Insulin-independent Therapeutic Approach for Treatment of Type 2 Diabetes: Focus On Canagliflozin." Diabetes Metab Syndr Obes 2015.

Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.